UPDATE 1-EC approves Novartis drug for rare cancer type
* Trial showed drug slashed risk of cancer progression
UPDATE 1-EC approves Novartis drug for rare cancer type | Reuters
ZURICH, Sept 5 (Reuters) - Swiss drugmaker Novartis AG's cancer drug Afinitor has received European Commission approval for the treatment of a rare type of .Read More
Novartis drug Afinitor® recommended by FDA oncology advisory ...
Novartis drug Afinitor® recommended by FDA oncology ... NET, also known as islet cell tumors, is a rare type of cancer ... and does not undertake any obligation to update .Read More
Novartis drug Afinitor® gains EU approval to treat patients with ...
Novartis drug Afinitor® gains EU approval to treat ... today that the European Commission has approved ... NET, also known as islet cell tumors, is a rare type of cancer .Read More
Brain Tumor News: U.S. Approves Novartis Cancer Drug Gleevec ...
breakthrough oral cancer drug that has shown dramatic results against a rare but deadly type ... Post An Update; Map of ... U.S. Approves Novartis Cancer Drug Gleevec .Read More
Pfizer, Novartis cancer drugs draw US FDA questions-UPDATE 4
staff also question Novartis cancer drug ... from Pfizer Inc and Novartis AG on two potential drugs for a rare form of pancreatic cancer ... to promote already approved cancer .Read More
UPDATE 1-Pfizer's Sutent approved for rare pancreatic cancer ...
NET is third cancer type Sutent approved for * Drug had ... UPDATE 1-Pfizer's Sutent approved for rare pancreatic cancer ... Novartis girds for rival .Read More
FDA approves Novartis drug Gleevec® label recommending extending ...
FDA approves Novartis drug Gleevec® label ... the US Food and Drug Administration (FDA) has approved an update to ... tumors are a rare, life-threatening cancer of the .Read More
Novartis says EU approves expanded use of Glivec
Novartis said Monday the European Union will allow it to expand its use of the drug Glivec to treat certain rare forms of gastrointestinal cancer. ... Type ... approved an update .Read More
Pfizer Drug Wins FDA Panel’s Backing for Pancreatic Cancer ...
marketing of a cancer drug for patients with the rare type of ... in New York, and Novartis want to sell their kidney-cancer drugs ... use of Afinitor, if approved .Read More
Novartis AG Gains FDA Approval for AfinitorR as
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration approved Afinitor ... tumors, is a rare type of cancer ... obligation to update .Read More
Gleevec™ for the Treatment of Chronic Myelogenous Leukemia: U.S ...
imatinib mesylate capsules, Novartis Pharmaceuticals), a drug ... mesylate the fastest FDA-approved cancer drug ever. ... in Patients with KRAS Wild-Type Colorectal Cancer .Read More
Data at ASH, SABCS demonstrate commitment of Novartis R&D in ...
commitment of Novartis R&D in advancing treatments for patients with cancer and rare diseases ... used to treat a type of ... Generic Drug Approvals; Monthly Update Archive.Read More
Novartis gets FDA approval for pancreatic cancer drug | Reuters
UPDATE 4-Tennis ... Reuters) - Novartis AG's (NOVN.VX) (NVS.N) cancer drug Afinitor has been approved by the U.S. Food and Drug Administration for a rare type of .Read More
Data at ASCO show promise of Novartis drugs for patients with life ...
Data at ASCO show promise of Novartis drugs for ... 533: Data from a five-year update of the ... has not yet been established in cancer and tumor types outside of the approved.Read More
Novartis’s Afinitor Wins FDA Approval for Jobs’s Cancer Type ...
Novartis AG won U.S. approval to expand marketing of its kidney-cancer drug Afinitor for patients with the rare type of pancreatic ... Bonuses If Court Approves.Read More
